233 related articles for article (PubMed ID: 16649829)
1. Effect of mirtazapine treatment on body composition and metabolism.
Laimer M; Kramer-Reinstadler K; Rauchenzauner M; Lechner-Schoner T; Strauss R; Engl J; Deisenhammer EA; Hinterhuber H; Patsch JR; Ebenbichler CF
J Clin Psychiatry; 2006 Mar; 67(3):421-4. PubMed ID: 16649829
[TBL] [Abstract][Full Text] [Related]
2. Glucose dysregulation and mirtazapine-induced weight gain.
Fisfalen ME; Hsiung RC
Am J Psychiatry; 2003 Apr; 160(4):797. PubMed ID: 12668379
[No Abstract] [Full Text] [Related]
3. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
Jiang SM; Jia L; Liu J; Shi MM; Xu MZ
World J Gastroenterol; 2016 Jun; 22(22):5260-6. PubMed ID: 27298569
[TBL] [Abstract][Full Text] [Related]
4. Changes in weight and glucose tolerance during treatment with mirtazapine.
Himmerich H; Fulda S; Schaaf L; Beitinger PA; Schuld A; Pollmächer T
Diabetes Care; 2006 Jan; 29(1):170. PubMed ID: 16373922
[No Abstract] [Full Text] [Related]
5. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine: clinical advantages in the treatment of depression.
Burrows GD; Kremer CM
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
[TBL] [Abstract][Full Text] [Related]
7. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Kraus T; Haack M; Schuld A; Hinze-Selch D; Koethe D; Pollmächer T
Pharmacopsychiatry; 2002 Nov; 35(6):220-5. PubMed ID: 12518269
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine augmentation in the treatment of refractory depression.
Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
[TBL] [Abstract][Full Text] [Related]
10. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
12. Dystonia induced by mirtazapine.
Lu R; Hurley AD; Gourley M
J Clin Psychiatry; 2002 May; 63(5):452-3. PubMed ID: 12019672
[No Abstract] [Full Text] [Related]
13. Urinary incontinence with mirtazapine.
Kunwar A; Virk S; Masand PS
J Clin Psychiatry; 2002 May; 63(5):454. PubMed ID: 12019674
[No Abstract] [Full Text] [Related]
14. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
Shen J; Moller HJ; Wang X; Chung SA; Shapiro GK; Li X; Shapiro CM
J Clin Psychiatry; 2009 Mar; 70(3):370-7. PubMed ID: 19192466
[TBL] [Abstract][Full Text] [Related]
15. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunction associated with mirtazapine: a case report.
Berigan TR; Harazin JS
J Clin Psychiatry; 1998 Jun; 59(6):319-20. PubMed ID: 9671348
[No Abstract] [Full Text] [Related]
17. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Schmid DA; Wichniak A; Uhr M; Ising M; Brunner H; Held K; Weikel JC; Sonntag A; Steiger A
Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
[TBL] [Abstract][Full Text] [Related]
18. The effects of mirtazapine on plasma lipid profiles in healthy subjects.
Nicholas LM; Ford AL; Esposito SM; Ekstrom RD; Golden RN
J Clin Psychiatry; 2003 Aug; 64(8):883-9. PubMed ID: 12927002
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine, an antidepressant.
Puzantian T
Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine for alcohol dependence: a case report.
Crockford DN; White WD
J Clin Psychiatry; 2005 Apr; 66(4):540. PubMed ID: 15816801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
